Back Home

  • Home
  • Overview
  • People
  • Results
  • Publications
  • Contact
  • Search
Back Home

  • Overview
  • Results
  • Publications
  • People
  • Contact

Clinical Investigator Collaborative

CIC is a multi-centre, Canadian-based Phase Ib & IIa clinical trials collaborative that fast-tracks drug candidates for the treatment of airways diseases.

OVERVIEW

Our expertise

CIC’s globally unique collaborative & proprietary SOPs deliver accurate, rapid & cost-effective early-stage clinical trial results to evaluate the efficacy of new molecules to treat airways diseases.

RESULTS

More than fee-for-service clinical trials

The CIC offers academic leadership in drug development research, conducts add-on experiments to establish the mechanism of action, and publishes novel data in high-impact scientific journals.

PUBLICATIONS

Overview

The Clinical Investigator Collaborative (CIC) is unique globally in its ability to undertake early-stage clinical trials to evaluate the efficacy of new molecules that treat inflammation in the airways.

Read More

People

CIC scientists, located at 6 sites across Canada, are opinion leaders renowned for their research accomplishments, their clinical expertise, and their ability to deliver high-quality results on time.

Read More

Results

CIC's track record conducting Phase Ib/IIa clinical trials of unsurpassed quality is attracting global investment and positioning Canada as a leader in airways disease research and drug development.

Read More

CIC completes 2-3 studies per year: avg. 50% crossover studies and 50% parallel studies.

Study metrics

Study outcomes

BRONCHOPROVOCATION Inhaled allergen (PC20/PD20, early & late asthmatic responses) Methacholine airway hyperresponsiveness Inhaled mannitol (Aridol®) Exercise-induced bronchoconstriction Hypertonic […]

Study methods

Across the Collaborative and within each study site, CIC employs the expertise of all the highly-trained research, technical […]

Staff

CIC has 6 sites across Canada and engagements with 5 international sites.

International engagements

CIC's accomplishments: from identifying new therapies to publishing novel data.

Accomplishments

The CIC is a Legacy Initiative of the Allergy, Genes and Environment Network (AllerGen)

© AllerGen NCE Inc. 2019

© 2023 – All rights reserved

WordPress Image Lightbox